These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3671730

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Direct evidence that thromboxane mimetic U44069 preferentially constricts the afferent arteriole.
    Hayashi K, Loutzenhiser R, Epstein M.
    J Am Soc Nephrol; 1997 Jan; 8(1):25-31. PubMed ID: 9013445
    [Abstract] [Full Text] [Related]

  • 24. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K, Halushka PV, Yan YT, Wong PY.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [Abstract] [Full Text] [Related]

  • 25. Thromboxane A2/prostaglandin H2 receptor antagonists.
    Le Breton GC, Lim CT, Vaidya CM, Venton DL.
    Methods Enzymol; 1990 Sep; 187():406-14. PubMed ID: 2146463
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues.
    Burke SE, Lefer AM, Nicolaou KC, Smith GM, Smith JB.
    Br J Pharmacol; 1983 Feb; 78(2):287-92. PubMed ID: 6831115
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
    Ashton JH, Schmitz JM, Campbell WB, Ogletree ML, Raheja S, Taylor AL, Fitzgerald C, Buja LM, Willerson JT.
    Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
    [Abstract] [Full Text] [Related]

  • 31. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
    Pfister SL, Pratt PE, Kurian J, Campbell WB.
    Vascul Pharmacol; 2004 Jan; 40(6):285-92. PubMed ID: 15063832
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Differential vasoreactivity to the thromboxane A2 mimic U-46619 of collateral and normal peripheral blood vessels in situ perfused rat hindquarters.
    Verheyen A, Lauwers F, Vlaminckx E, De Clerck F.
    Blood Vessels; 1989 Jan; 26(3):165-76. PubMed ID: 2790215
    [Abstract] [Full Text] [Related]

  • 35. Influence of SQ 29,548 on vasoconstrictor responses in the mesenteric vascular bed of the cat.
    Minkes RK, Lippton HL, Armstead WM, Lepak KA, Higuera TR, McNamara DB, Kadowitz PJ.
    Eur J Pharmacol; 1990 Apr 10; 179(1-2):119-27. PubMed ID: 2364976
    [Abstract] [Full Text] [Related]

  • 36. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
    Cozzi P, Giordani A, Menichincheri M, Pillan A, Pinciroli V, Rossi A, Tonani R, Volpi D, Tamburin M, Ferrario R.
    J Med Chem; 1994 Oct 14; 37(21):3588-604. PubMed ID: 7932586
    [Abstract] [Full Text] [Related]

  • 37. Blockade of thromboxane and the prevention of eicosanoid-induced sudden death in mice.
    Darius H, Lefer AM.
    Proc Soc Exp Biol Med; 1985 Nov 14; 180(2):364-8. PubMed ID: 2996012
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.
    Nicolaou KC, Magolda RL, Smith JB, Aharony D, Smith EF, Lefer AM.
    Proc Natl Acad Sci U S A; 1979 Jun 14; 76(6):2566-70. PubMed ID: 288046
    [Abstract] [Full Text] [Related]

  • 39. A proposed common spatial pharmacophore and the corresponding active conformations of some TxA2 receptor antagonists.
    Jin B, Hopfinger AJ.
    J Chem Inf Comput Sci; 1994 Jun 14; 34(4):1014-21. PubMed ID: 7929664
    [Abstract] [Full Text] [Related]

  • 40. Thromboxane synthetase inhibitors differentially antagonize thromboxane receptors in vascular smooth muscle.
    Smith EF, Lefer AM, Smith JB, Nicolaou KC.
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec 14; 318(2):130-4. PubMed ID: 6276789
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.